SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-150798
Filing Date
2018-05-03
Accepted
2018-05-03 16:06:54
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d557887d10q.htm 10-Q 324550
2 EX-31.1 d557887dex311.htm EX-31.1 6166
3 EX-31.2 d557887dex312.htm EX-31.2 6433
4 EX-32 d557887dex32.htm EX-32 4921
  Complete submission text file 0001193125-18-150798.txt   2858205

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20180331.xml EX-101.INS 577630
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20180331.xsd EX-101.SCH 29282
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20180331_cal.xml EX-101.CAL 39038
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20180331_def.xml EX-101.DEF 122722
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20180331_lab.xml EX-101.LAB 292835
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20180331_pre.xml EX-101.PRE 213437
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 18803774
SIC: 2834 Pharmaceutical Preparations